Role of Topical Vancomycin in Reducing Infections in Hip and Knee Arthroplasty
NCT ID: NCT05972603
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1000 participants
INTERVENTIONAL
2022-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical Vancomycin for Infection Prophylaxis in TJA
NCT04993027
Intrawound Administration of Vancomycin in THA
NCT05338008
Preoperative Bath in Patients Submitted to Hip Arthroplasty
NCT03001102
CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
NCT05828810
Influence of Antiseptic Washes on Wound Healing Complications After THA
NCT07104084
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients drawn by random numbers calculator will be administered with 1.0 g Vancomycin powder into the wound around the prosthesis and no suction will be used.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0,35% povidone-iodine solution lavage
0,35% povidone-iodine solution lavage left in wound for 3 minutes following final implantation.
0,35% povidone-iodine solution lavage
0,35% povidone-iodine solution lavage left for 3 minutes following final implantation
1.0 g Vancomycin powder into the wound
additional 1.0 g Vancomycin powder into the wound
1.0 g Vancomycin powder into the wound
0,35% povidone-iodine solution lavage left for 3 minutes following final implantation and additional application 1.0 g Vancomycin powder into the wound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1.0 g Vancomycin powder into the wound
0,35% povidone-iodine solution lavage left for 3 minutes following final implantation and additional application 1.0 g Vancomycin powder into the wound
0,35% povidone-iodine solution lavage
0,35% povidone-iodine solution lavage left for 3 minutes following final implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Independent Public Healthcare Center in Rypin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IPHC Rypin
Rypin, Kujawsko-pomorksie, Poland
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kulakowski M, Elster K, Szymczak M, Sleczka P, Baumgart M, Krolikowska A, Reichert P. Comparison of the effect of combined usage of povidone-iodine irrigation and topical vancomycin powder to the use of povidone-iodine irrigation alone on the periprosthetic joint infection incidence rate in patients undergoing primary total hip and knee arthroplasty: a protocol for multicenter prospective randomized clinical trial. Trials. 2024 Jul 10;25(1):468. doi: 10.1186/s13063-024-08306-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.